Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-IgG) (BSIG-113)

Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD32B and anti-malaria antigen parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD32B & malaria antigen

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD32B

Gene ID

2213

UniProt ID

P31994

Alternative Names

FCGR2B; Fc fragment of IgG, low affinity IIb, receptor (CD32); FcγRIIB; CD32; FCG2; CD32B; FCGR2; IGFR2; low affinity immunoglobulin gamma Fc region receptor II-b; CDw32; fcRII-b; Fc gamma RIIb; fc-gamma-RIIb; fc-gamma RII-b; igG Fc receptor II-b; Fc fragment of IgG, low affinity II, receptor for (CD32); Fc fragment of IgG, low affinity IIb, receptor for (CD32)

Target 2

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD32B & malaria antigen"

See other bsAb targets related to "CD32B"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-IgG) (BSIG-113). Click the button below to contact us or submit your feedback about this product.

Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-IgG) (CAT#: BSIG-113)

Specifications

Targets

Customer Reviews and Q&As